We are live on
!
Find out more
FPF
FNY Partners Fund Portfolio holdings
AUM
$185M
1-Year Est. Return
32.58%
This Fund
S&P 500
This Quarter
Est. Return
+3.34%
1 Year Est. Return
+32.58%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$602M
AUM Growth
+$13.9M
(+2.4%)
Cap. Flow
+$30M
Cap. Flow
% of AUM
4.99%
Top 10 Holdings %
Top 10 Hldgs %
53.67%
Holding
779
New
226
Increased
80
Reduced
80
Closed
350
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$54.6M |
| 2 |
Honda
HMC
|
+$15.4M |
| 3 |
HSNI
HSN, Inc.
HSNI
|
+$15.3M |
| 4 |
Novartis
NVS
|
+$12M |
| 5 |
ASML
ASML
|
+$11.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
+$68.2M |
| 2 |
ALR
Alere Inc
ALR
|
+$25M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$17.2M |
| 4 |
PRXL
Parexel International Corp
PRXL
|
+$10.2M |
| 5 |
Huntsman Corp
HUN
|
+$9.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.86% |
| 2 | Technology | 15.71% |
| 3 | Consumer Discretionary | 14.51% |
| 4 | Financials | 11.02% |
| 5 | Consumer Staples | 8.13% |
Similar funds
USG2
PAM
HWP
IHM
EP
DVM
LCM
PAM
FNY Partners Fund's Q4 2017 Portfolio in Review
As of Q4 2017, FNY Partners Fund held 779 positions worth $602M, up 2.4% from $588M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
FNY Partners Fund deployed $30M of net new capital in Q4 2017, opening 226 new positions and adding to 80 existing holdings. Its largest new stake was HSN, Inc.: 388,145 shares worth $15.7M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Time Warner Inc, an estimated $17.2M trimmed.
- FNY Partners Fund's largest Q4 2017 buy was HSN, Inc.: 388,145 shares worth $15.7M.
- FNY Partners Fund added most to Shire pic in Q4 2017, an estimated $54.6M increase.
- FNY Partners Fund's biggest Q4 2017 reduction was Time Warner Inc, cutting an estimated $17.2M.
- FNY Partners Fund fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $68.2M.
- FNY Partners Fund's ten largest holdings make up 54% of its $602M portfolio in Q4 2017.
- FNY Partners Fund opened 226 new positions and closed 350 in Q4 2017.
- FNY Partners Fund's portfolio value rose 2.4% quarter-over-quarter to $602M.
Based on FNY Partners Fund's 13F filing for Q4 2017, filed 24 Jan 2018.